AI assistant
Sending…
Cyclerion Therapeutics, Inc. — Director's Dealing 2019
Apr 3, 2019
35315_dirs_2019-04-03_560c2d35-a900-41e9-839d-c062bd7ecd3d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cyclerion Therapeutics, Inc. (CYCN)
CIK: 0001755237
Period of Report: 2019-04-01
Reporting Person: Churchwell Kevin (Director)
More from Cyclerion Therapeutics, Inc.
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 18
M&A Activity
2026
Apr 1
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2025
Dec 1
Interim / Quarterly Report
2025
Nov 12
Annual Report
2025
Nov 12
Major Shareholding Notification
2025
Oct 17
Investor Presentation
2025
Sep 23